A citation-based method for searching scientific literature

N Müller, M J Schwarz, S Dehning, A Douhe, A Cerovecki, B Goldstein-Müller, I Spellmann, G Hetzel, K Maino, N Kleindienst, H-J Möller, V Arolt, M Riedel. Mol Psychiatry 2006
Times Cited: 504







List of co-cited articles
1409 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


A meta-analysis of cytokines in major depression.
Yekta Dowlati, Nathan Herrmann, Walter Swardfager, Helena Liu, Lauren Sham, Elyse K Reim, Krista L Lanctôt. Biol Psychiatry 2010
38

From inflammation to sickness and depression: when the immune system subjugates the brain.
Robert Dantzer, Jason C O'Connor, Gregory G Freund, Rodney W Johnson, Keith W Kelley. Nat Rev Neurosci 2008
33

Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: randomized double-blind placebo-controlled study.
Seyed-Hesameddin Abbasi, Fahimeh Hosseini, Amirhossein Modabbernia, Mandana Ashrafi, Shahin Akhondzadeh. J Affect Disord 2012
177
30

Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial.
Shahin Akhondzadeh, Sara Jafari, Firoozeh Raisi, Abbas Ali Nasehi, Aboulfazl Ghoreishi, Bahman Salehi, Soodeh Mohebbi-Rasa, Maedeh Raznahan, Abbas Kamalipour. Depress Anxiety 2009
233
29

A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers.
Charles L Raison, Robin E Rutherford, Bobbi J Woolwine, Chen Shuo, Pamela Schettler, Daniel F Drake, Ebrahim Haroon, Andrew H Miller. JAMA Psychiatry 2013
819
26

Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials.
Ole Köhler, Michael E Benros, Merete Nordentoft, Michael E Farkouh, Rupa L Iyengar, Ole Mors, Jesper Krogh. JAMA Psychiatry 2014
420
26

Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression.
Andrew H Miller, Vladimir Maletic, Charles L Raison. Biol Psychiatry 2009
25

Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis.
M Bryant Howren, Donald M Lamkin, Jerry Suls. Psychosom Med 2009
25

Shortened onset of action of antidepressants in major depression using acetylsalicylic acid augmentation: a pilot open-label study.
Julien Mendlewicz, Philippe Kriwin, Pierre Oswald, Daniel Souery, Silvia Alboni, Nicoletta Brunello. Int Clin Psychopharmacol 2006
155
21


Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial.
Stephen Tyring, Alice Gottlieb, Kim Papp, Ken Gordon, Craig Leonardi, Andrea Wang, Deepa Lalla, Michael Woolley, Angelika Jahreis, Ralph Zitnik,[...]. Lancet 2006
715
19

Cytokines sing the blues: inflammation and the pathogenesis of depression.
Charles L Raison, Lucile Capuron, Andrew H Miller. Trends Immunol 2006
17


Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double-blind, randomized, placebo-controlled study.
Fabiano G Nery, Emel S Monkul, John P Hatch, Manoela Fonseca, Giovana B Zunta-Soares, Benício N Frey, Charles L Bowden, Jair C Soares. Hum Psychopharmacol 2008
195
14



The macrophage theory of depression.
R S Smith. Med Hypotheses 1991
598
13

Inflammation and clinical response to treatment in depression: A meta-analysis.
R Strawbridge, D Arnone, A Danese, A Papadopoulos, A Herane Vives, A J Cleare. Eur Neuropsychopharmacol 2015
266
13

Cumulative meta-analysis of interleukins 6 and 1β, tumour necrosis factor α and C-reactive protein in patients with major depressive disorder.
Rita Haapakoski, Julia Mathieu, Klaus P Ebmeier, Harri Alenius, Mika Kivimäki. Brain Behav Immun 2015
423
12

Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies.
C A Köhler, T H Freitas, M Maes, N Q de Andrade, C S Liu, B S Fernandes, B Stubbs, M Solmi, N Veronese, N Herrmann,[...]. Acta Psychiatr Scand 2017
396
12

Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice.
J C O'Connor, M A Lawson, C André, M Moreau, J Lestage, N Castanon, K W Kelley, R Dantzer. Mol Psychiatry 2009
722
12

The effect of adalimumab on reducing depression symptoms in patients with moderate to severe psoriasis: a randomized clinical trial.
Alan Menter, Matthias Augustin, James Signorovitch, Andrew P Yu, Eric Q Wu, Shiraz R Gupta, Yanjun Bao, Parvez Mulani. J Am Acad Dermatol 2010
92
11

The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis.
Jonas Hannestad, Nicole DellaGioia, Michael Bloch. Neuropsychopharmacology 2011
526
11

Efficacy of adjunctive celecoxib treatment for patients with major depressive disorder: a meta-analysis.
Kyoung-Sae Na, Kang Joon Lee, Ji Sung Lee, Young Sung Cho, Han-Yong Jung. Prog Neuropsychopharmacol Biol Psychiatry 2014
96
11


Inflammation in Depression and the Potential for Anti-Inflammatory Treatment.
Ole Kohler, Jesper Krogh, Ole Mors, Michael Eriksen Benros. Curr Neuropharmacol 2016
148
11

Autoimmune diseases and severe infections as risk factors for mood disorders: a nationwide study.
Michael E Benros, Berit L Waltoft, Merete Nordentoft, Søren D Ostergaard, William W Eaton, Jesper Krogh, Preben B Mortensen. JAMA Psychiatry 2013
253
11

Plasma cytokine profiles in depressed patients who fail to respond to selective serotonin reuptake inhibitor therapy.
Sinead M O'Brien, Paul Scully, Peter Fitzgerald, Lucinda V Scott, Timothy G Dinan. J Psychiatr Res 2007
256
10

Cytokine-associated emotional and cognitive disturbances in humans.
A Reichenberg, R Yirmiya, A Schuld, T Kraus, M Haack, A Morag, T Pollmächer. Arch Gen Psychiatry 2001
844
10


Immune system to brain signaling: neuropsychopharmacological implications.
Lucile Capuron, Andrew H Miller. Pharmacol Ther 2011
582
10

Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes.
Elaine Setiawan, Alan A Wilson, Romina Mizrahi, Pablo M Rusjan, Laura Miler, Grazyna Rajkowska, Ivonne Suridjan, James L Kennedy, P Vivien Rekkas, Sylvain Houle,[...]. JAMA Psychiatry 2015
386
10

A Randomized, Double-blind, Placebo-controlled Trial of Celecoxib Augmentation of Sertraline in Treatment of Drug-naive Depressed Women: A Pilot Study.
Marzieh Majd, Farshad Hashemian, Seyed Mohammad Hosseini, Maryam Vahdat Shariatpanahi, Ali Sharifi. Iran J Pharm Res 2015
21
47


Evidence for an immune response in major depression: a review and hypothesis.
M Maes. Prog Neuropsychopharmacol Biol Psychiatry 1995
679
9

Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: evidence for an immune-modulated glutamatergic neurotransmission?
Johann Steiner, Martin Walter, Tomasz Gos, Gilles J Guillemin, Hans-Gert Bernstein, Zoltán Sarnyai, Christian Mawrin, Ralf Brisch, Hendrik Bielau, Louise Meyer zu Schwabedissen,[...]. J Neuroinflammation 2011
321
9

NLRP3 inflammasome is activated in mononuclear blood cells from patients with major depressive disorder.
Elísabet Alcocer-Gómez, Manuel de Miguel, Nieves Casas-Barquero, Jéssica Núñez-Vasco, José Antonio Sánchez-Alcazar, Ana Fernández-Rodríguez, Mario D Cordero. Brain Behav Immun 2014
197
9

Raised plasma levels of tumor necrosis factor alpha in patients with depression: normalization during electroconvulsive therapy.
Knut A Hestad, Sverre Tønseth, Charlotte D Støen, Thor Ueland, Pål Aukrust. J ECT 2003
156
9

Pro-inflammatory cytokines and treatment response to escitalopram in major depressive disorder.
Triin Eller, Veiko Vasar, Jakov Shlik, Eduard Maron. Prog Neuropsychopharmacol Biol Psychiatry 2008
205
9


The expression of genes encoding for COX-2, MPO, iNOS, and sPLA2-IIA in patients with recurrent depressive disorder.
Piotr Gałecki, Elżbieta Gałecka, Michael Maes, Marcelina Chamielec, Agata Orzechowska, Kinga Bobińska, Andrzej Lewiński, Janusz Szemraj. J Affect Disord 2012
79
11

Cytokines and major depression.
Olga J G Schiepers, Marieke C Wichers, Michael Maes. Prog Neuropsychopharmacol Biol Psychiatry 2005
757
9

Elevated C-reactive protein levels, psychological distress, and depression in 73, 131 individuals.
Marie Kim Wium-Andersen, David Dynnes Ørsted, Sune Fallgaard Nielsen, Børge Grønne Nordestgaard. JAMA Psychiatry 2013
236
8

Ustekinumab significantly improves symptoms of anxiety, depression, and skin-related quality of life in patients with moderate-to-severe psoriasis: Results from a randomized, double-blind, placebo-controlled phase III trial.
Richard G Langley, Steven R Feldman, Chenglong Han, Brad Schenkel, Philippe Szapary, Ming-Chun Hsu, Jean-Paul Ortonne, Kenneth B Gordon, Alexa B Kimball. J Am Acad Dermatol 2010
113
8

NSAIDs are associated with lower depression scores in patients with osteoarthritis.
Rupa L Iyengar, Sumeet Gandhi, Ashish Aneja, Kevin Thorpe, Louai Razzouk, Jeffery Greenberg, Serge Mosovich, Michael E Farkouh. Am J Med 2013
48
16

Simvastatin as an adjuvant therapy to fluoxetine in patients with moderate to severe major depression: A double-blind placebo-controlled trial.
Amirhossein Gougol, Nahid Zareh-Mohammadi, Samira Raheb, Mehdi Farokhnia, Samrand Salimi, Negar Iranpour, Habibeh Yekehtaz, Shahin Akhondzadeh. J Psychopharmacol 2015
33
24

An inflammatory biomarker as a differential predictor of outcome of depression treatment with escitalopram and nortriptyline.
Rudolf Uher, Katherine E Tansey, Tracy Dew, Wolfgang Maier, Ole Mors, Joanna Hauser, Mojca Zvezdana Dernovsek, Neven Henigsberg, Daniel Souery, Anne Farmer,[...]. Am J Psychiatry 2014
191
8

Pioglitazone adjunctive therapy for moderate-to-severe major depressive disorder: randomized double-blind placebo-controlled trial.
Khatereh Sepanjnia, Amirhossein Modabbernia, Mandana Ashrafi, Mohammad-Jafar Modabbernia, Shahin Akhondzadeh. Neuropsychopharmacology 2012
82
9

Cytokine production and treatment response in major depressive disorder.
S Lanquillon, J C Krieg, U Bening-Abu-Shach, H Vedder. Neuropsychopharmacology 2000
494
8

Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report.
A John Rush, Madhukar H Trivedi, Stephen R Wisniewski, Andrew A Nierenberg, Jonathan W Stewart, Diane Warden, George Niederehe, Michael E Thase, Philip W Lavori, Barry D Lebowitz,[...]. Am J Psychiatry 2006
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.